Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Cadrenal Therapeutics, Inc. Common Stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $0.00 | $0.00 - $0.00 | $0.00 | $8.55 | 0 |
| Dec 2028 | $16.80M | $16.80M - $16.80M | $0.00 | -$2.61 | 2 |
| Dec 2027 | $6.30M | $6.30M - $6.30M | $0.00 | -$3.42 | 2 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$5.523 | 0 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$6.36 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$7.60 | 0 |